Vycor Medical (VYCO) Net Income towards Common Stockholders (2010 - 2026)
Vycor Medical's (VYCO) quarterly Net Income towards Common Stockholders came in at -$22288.0 in Q2 2026, down 193.31% year-over-year from $23887.0 in Q2 2025, and up 84.31% quarter-over-quarter from -$142077.0 in Q1 2026.
Powered by 
Analysis
Vycor Medical (VYCO) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Net Income towards Common Stockholders for 17 consecutive years, with -$22288.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 193.31% year-over-year to -$22288.0 in Q2 2026; TTM through Jun 2026 was -$384300.0, a 5.25% increase from a year earlier, with the FY2025 full-year figure at -$396796.0, up 8.06% from the prior year.
- Net Income towards Common Stockholders was -$22288.0 for Q2 2026 at Vycor Medical, up from -$142077.0 in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $68406.0 in Q2 2023 and troughed at -$276992.0 in Q3 2022.
- A 5-year average of -$117559.9 and a median of -$129312.5 in 2022 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders sank 956.22% in 2022 and surged 337.97% in 2025, its largest moves.
- Over 5 years, Net Income towards Common Stockholders stood at -$116548.0 in 2022, then increased by 20.16% to -$93055.0 in 2023, then soared by 92.76% to -$6737.0 in 2024, then sank by 830.47% to -$62686.0 in 2025, then soared by 64.45% to -$22288.0 in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$22288.0 (Q2 2026), -$142077.0 (Q1 2026), and -$62686.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 907.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -22,288.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22,288.00 |
| Mar 31, 2026 | -142,077.00 |
| Dec 31, 2025 | -62,686.00 |
| Sep 30, 2025 | -157,249.00 |
| Jun 30, 2025 | 23,887.00 |
| Mar 31, 2025 | -200,748.00 |
| Dec 31, 2024 | -6,737.00 |
| Sep 30, 2024 | -222,002.00 |
| Jun 30, 2024 | -10,038.00 |
| Mar 31, 2024 | -192,793.00 |
| Dec 31, 2023 | -93,055.00 |
| Sep 30, 2023 | -214,089.00 |
| Jun 30, 2023 | 68,406.00 |
| Mar 31, 2023 | -155,323.00 |
| Dec 31, 2022 | -116,548.00 |
| Sep 30, 2022 | -276,992.00 |
| Jun 30, 2022 | -99,010.00 |
| Mar 31, 2022 | -236,737.00 |
| Dec 31, 2021 | -187,062.00 |
| Sep 30, 2021 | -158,492.00 |